In our study, we found that, among the five SFXN members, SFXN4 expression was the highest and consistently elevated in HCC, and elevation of SFXN4 correlated significantly with HCC progression and prognosis. The gene discussed is SFXN4; the disease is hepatocellular carcinoma.